# Rifadin IV

NDC: 0068-0597
Generic name: rifampin
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 19890525
Marketing ended: 20260930
FDA application: NDA050627

## Active ingredients

- RIFAMPIN: 600 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0068-0597"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0068-0597
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab